These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15924589)

  • 1. Diagnosis of impaired glucose tolerance in hypertensive patients in daily clinical practice.
    Lüders S; Hammersen F; Kulschewski A; Venneklaas U; Züchner C; Gansz A; Schnieders M; Pfarr E; Sturm CD; Paar WD; Schrader J
    Int J Clin Pract; 2005 Jun; 59(6):632-8. PubMed ID: 15924589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of capillary glucose measurements to detect glucose intolerance or type 2 diabetes mellitus in the general population.
    Kruijshoop M; Feskens EJ; Blaak EE; de Bruin TW
    Clin Chim Acta; 2004 Mar; 341(1-2):33-40. PubMed ID: 14967156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetic analysis in the evaluation of glucose tolerance disorders. Evaluation and use of a new method in the diagnosis of glucose tolerance in clinical practice].
    Stejskal D; Mohapl P; Pastorková R; Bártek J; Chlup R; Hrbková M
    Vnitr Lek; 1997 Jun; 43(6):379-87. PubMed ID: 9601869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glucose tolerance test in Italian overweight/obese children and adolescents results in a very high prevalence of impaired fasting glycaemia, but not of diabetes.
    Cambuli VM; Incani M; Pilia S; Congiu T; Cavallo MG; Cossu E; Sentinelli F; Mariotti S; Loche S; Baroni MG
    Diabetes Metab Res Rev; 2009 Sep; 25(6):528-34. PubMed ID: 19496065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
    Rush E; Crook N; Simmons D
    Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose intolerance and cardiometabolic risk in children exposed to maternal gestational diabetes mellitus in utero.
    Tam WH; Ma RC; Yang X; Ko GT; Tong PC; Cockram CS; Sahota DS; Rogers MS; Chan JC
    Pediatrics; 2008 Dec; 122(6):1229-34. PubMed ID: 19047239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a physiologic oral glucose solution for screening for impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Phillips WT; Tilson KS; Schwartz JG
    Arch Pathol Lab Med; 1996 Sep; 120(9):842-6. PubMed ID: 9140289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes.
    Bajraktari G; Koltai MS; Ademaj F; Rexhepaj N; Qirko S; Ndrepepa G; Elezi S
    Int J Cardiol; 2006 Jun; 110(2):206-11. PubMed ID: 16297997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of impaired glucose tolerance and diabetes mellitus in subjects with fasting blood glucose below 6.1 mmol/L (110 mg/dL).
    Khan SH; Ijaz A; Bokhari SA; Hanif MS; Azam N
    East Mediterr Health J; 2013 Feb; 19(2):175-80. PubMed ID: 23516829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vibrotactile sense in median and ulnar nerve innervated fingers of men with Type 2 diabetes, normal or impaired glucose tolerance.
    Dahlin LB; Thrainsdottir S; Cederlund R; Thomsen NO; Eriksson KF; Rosén I; Speidel T; Sundqvist G
    Diabet Med; 2008 May; 25(5):543-9. PubMed ID: 18346156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
    da Silva RC; Miranda WL; Chacra AR; Dib SA
    J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients.
    Gianotti N; Visco F; Galli L; Barda B; Piatti P; Salpietro S; Bigoloni A; Vinci C; Nozza S; Gallotta G; Lazzarin A; Castagna A
    HIV Med; 2011 Feb; 12(2):109-17. PubMed ID: 20629770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome.
    Bakris G; Molitch M; Hewkin A; Kipnes M; Sarafidis P; Fakouhi K; Bacher P; Sowers J;
    Diabetes Care; 2006 Dec; 29(12):2592-7. PubMed ID: 17130190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.